September 21, 2017

Collagen Solutions Engineering towards CE Mark

Collagen Solutions Plc (LON:COS) is a biomaterials company developing and manufacturing medical grade collagen components for use in medical devices, research, and regenerative medicine. A number of investment initiatives have..

Redstoneconnect PLC Q&A: £5.5 Million Contract Win & Trading Update (LON:REDS)

Redstoneconnect PLC (LON:REDS) Chief Executive Officer Mark Braund caught up with DirectorsTalk for an exclusive interview to discuss their £5.5 million contract win, their latest trading update & what investors..

Gateley (Holdings) Plc FY 17 results and initiation

Gateley (Holdings) Plc (LON:GTLY) is a broad-based UK legal services firm. It floated on AIM in mid-2015. It is a leader in the UK mid market, having grown strongly over..

1pm plc Q&A with Hardman & Co’s Analyst Mark Thomas (LON:OPM)

1pm plc (LON:OPM) is the topic of conversation when Hardman and Co’s Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview   Q1: Mark, why is the SME..

Gateley Holdings PLC – Hardman Research: FY17 Results and Initiation

Gateley Holdings PLC (LON:GTLY) is a broad-based UK legal services firm. It floated on AIM in mid-2015. It is a leader in the UK mid market, having grown strongly over..

Xafinity PLC Q&A with Zeus Capital’s Research Director Robin Savage (LON:XAF)

Xafinity Plc (LON:XAF) is the topic of conversation when Zeus Capital’s Research Director Robin Savage caught up with DirectorsTalk for an exclusive interview   Q1: The CMA announced that it..

Marshall Motor Holdings Plc To sell Marshall Leasing Limited

Marshall Motor Holdings plc, (LON:MMH) one of the UK’s leading automotive retail groups, announced today the proposed strategic disposal (“Disposal”) of its wholly-owned leasing segment, Marshall Leasing Limited (“MLL” or..

Collagen Solutions Plc Patient Assessments Completed, Analysis Ongoing

Collagen Solutions plc (LON:COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announced today that the final patient has..

Deltex Medical Group plc Release and first sale of HD-ICG in France

Deltex Medical Group plc (LON:DEMG), the global leader in oesophageal Doppler monitoring (“ODM”) today announced the release and first sales of its new High Definition Impedance Cardiography (HD-ICG) modality in..

INTERVIEW: Savannah Resources Plc High Grade Lithium may be Fast Tracked

Savannah Resources Plc (LON:SAV) CEO David Archer talks to DirectorsTalk about the current level of interest in Lithium, what David likes about the Mina do Barroso project, with the news..

AIM Oil & Gas Exploration & Production review

After enjoying a flood of investment in July, the level of new funds finding their way into AIM’s Oil & Gas Exploration & Production sector slowed to a trickle in..

Safestyle UK plc Shares offer an attractive 6.1% dividend yield – Zeus

Safestyle UK Plc (LON:SFE) has released interim results for the six months ended 30 June. Revenue of £82.5m is +1.4% YoY (HY16 restated: £81.4m) however an increase in costs driven..

Cambridge Cognition Holdings plc Investment reaps rewards with record sales pipeline

Cambridge Cognition Holdings plc, (LON:COG), The neuroscience digital health company which develops and markets software products to improve brain health, announced today its unaudited Interim Results for the six months..

Immupharma PLC Update on LupuzorT Pivotal Phase III Study

ImmuPharma PLC (LON:IMM), the specialist drug discovery and development company, has today provided the following update of its pivotal 52-week, randomised, double-blinded, Phase III clinical trial of Lupuzor™, its lead..

Search

Funds

September 21, 2017

Search

Funds

September 21, 2017

FTSE 100

Funds